• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

AmerisourceBergen

Anonymous Board for AmerisourceBergen.
Replies
0
Views
2K
anonymous
2
Replies
0
Views
607
anonymous
Replies
0
Views
969
anonymous
Replies
1
Views
7K
anonymous
Replies
1
Views
2K
anonymous
Replies
0
Views
2K
anonymous
Replies
21
Views
14K
anonymous
Replies
0
Views
2K
anonymous
Replies
2
Views
3K
anonymous
Replies
0
Views
3K
anonymous
Replies
0
Views
3K
labellingmachine
Replies
0
Views
6K
Anonymous
Replies
1
Views
5K
Anonymous
Replies
1
Views
7K
Anonymous
Replies
13
Views
9K
Anonymous
Replies
0
Views
4K
FootSalesManager